Skip to content
National Cancer Institute
U.S. National Institutes of Health
| www.cancer.gov
In English |
En español
Search
NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
Clinical Trials Search Results
Quick Links
Director's Corner
Dictionary of Cancer Terms
NCI Drug Dictionary
Funding Opportunities
NCI Publications
Advisory Boards and Groups
Science Serving People
Español
Questions about cancer?
1-800-4-CANCER
LiveHelp® online chat
NCI Highlights
High Dose Chemotherapy Prolongs Survival for Leukemia
Prostate Cancer Study Shows No Benefit for Selenium, Vitamin E
Past Highlights
Results:
1 -3 of 3
Show
10
25
50
100
200
results per page
View Search Criteria
|
Help With Results
Sort By:
Phase of Trial
Title
Type of Trial
Status of Trial
Age Range
Sponsor of Trial
Protocol IDs
Version:
Health Professional
Patient
Format:
Short
------
Short
Medium
Long
Custom
Last Modified:
10/10/2008
 
First Published:
2/20/2004
1.
Phase II Study of Pirfenidone in Pediatric Patients With Neurofibromatosis Type I and Recurrent or Progressive Plexiform Neurofibromas
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Treatment
Closed
3 to 21
NCI
NCI-04-C-0080
NCT00078936
Last Modified:
10/31/2007
 
First Published:
1/26/2003
2.
Phase I Study of Pirfenidone in Pediatric Patients With Neurofibromatosis Type 1 and Plexiform Neurofibromas
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase I
Prevention
Completed
3 to 21
NCI
NCI-03-C-0058A
NCT00053937
Last Modified:
8/10/2004
 
First Published:
6/1/2001
3.
Pilot Study of Pirfenidone in Cancer Patients With Radiation-Induced Fibrosis
Phase
Type
Status
Age
Sponsor
Protocol IDs
No phase specified
Supportive care
Completed
18 and over
NCI
NCI-01-C-0143
NCT00020631
Select All on One Page
NCI Home
|
Images Version
|
Contact Us
|
Policies
|
Accessibility
|
Viewing Files
|
FOIA
|
Site Help
|
Site Map
A Service of the National Cancer Institute